Neuberger Berman Group LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$317,000
-75.7%
9,670
-65.8%
0.00%
-100.0%
Q3 2021$1,304,000
-28.1%
28,307
-14.1%
0.00%
-50.0%
Q2 2021$1,814,000
-8.2%
32,972
-14.0%
0.00%0.0%
Q1 2021$1,976,000
+15.5%
38,332
-3.0%
0.00%0.0%
Q4 2020$1,711,000
+20.5%
39,533
-2.6%
0.00%0.0%
Q3 2020$1,420,000
-46.2%
40,581
-17.8%
0.00%
-33.3%
Q2 2020$2,641,000
+46.6%
49,391
-2.8%
0.00%0.0%
Q1 2020$1,802,000
-51.4%
50,792
-34.5%
0.00%
-25.0%
Q4 2019$3,705,000
+71.4%
77,598
+16.3%
0.00%
+33.3%
Q3 2019$2,161,000
-52.5%
66,699
-26.8%
0.00%
-40.0%
Q2 2019$4,546,000
-29.6%
91,139
-4.8%
0.01%
-37.5%
Q1 2019$6,458,000
-46.9%
95,763
-63.7%
0.01%
-52.9%
Q4 2018$12,156,000
-54.1%
263,616
-23.2%
0.02%
-43.3%
Q3 2018$26,482,000
-7.1%
343,391
+1.5%
0.03%
-3.2%
Q2 2018$28,499,000
+48.3%
338,355
+44.0%
0.03%
+40.9%
Q1 2018$19,213,000
+1972.6%
234,940
+1349.4%
0.02%
+2100.0%
Q4 2017$927,000
+24.9%
16,210
+106.1%
0.00%0.0%
Q1 2015$742,000
+186.5%
7,865
+239.6%
0.00%
Q4 2014$259,0002,3160.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders